Back

Results - Announcements
Sandu Pharmaceuticals standalone net profit declines 9.09% in the September 2024 quarter As on : 15-Nov-24  15:08

Net profit of Sandu Pharmaceuticals declined 9.09% to Rs 0.50 crore in the quarter ended September 2024 as against Rs 0.55 crore during the previous quarter ended September 2023. Sales rose 6.56% to Rs 17.70 crore in the quarter ended September 2024 as against Rs 16.61 crore during the previous quarter ended September 2023.

ParticularsQuarter Ended
Sep. 2024Sep. 2023% Var.
Sales17.7016.61 7
OPM %5.144.88 -
PBDT0.910.89 2
PBT0.740.76 -3
NP0.500.55 -9

Powered by Capital Market - Live News